No, do not use Augmentin 500-125 mg BID for a 20-kg child
For a 20-kg child, you should prescribe weight-based dosing of amoxicillin 90 mg/kg/day (1800 mg/day total) divided twice daily, not the adult Augmentin 500-125 mg BID formulation, which would provide only 1000 mg/day of amoxicillin—a 44% underdose.
Why Weight-Based Dosing is Critical
The IDSA/PIDS pediatric pneumonia guidelines explicitly recommend amoxicillin 90 mg/kg/day in 2 doses as the preferred oral therapy for Streptococcus pneumoniae with penicillin MICs <2.0 µg/mL 1, 2. For a 20-kg child, this translates to:
- Target dose: 1800 mg amoxicillin per day (900 mg BID)
- Augmentin 500-125 BID provides: Only 1000 mg amoxicillin per day (500 mg BID)
- Deficit: 800 mg/day shortfall
The Pharmacokinetic Rationale
Children ≥2 years are metabolically mature but differ from adults in size, not physiology 3. Drug elimination scales with body surface area and metabolic capacity, not linearly with weight. Simply using adult tablets in children results in systematic underdosing 4, 3.
Key principle: Weight-based dosing (mg/kg) should be used for all children <40 kg 5. Once the calculated dose exceeds the standard adult dose, you cap at the adult maximum—but a 20-kg child requiring 1800 mg/day is well below adult dosing limits.
Appropriate Formulation Options
For this 20-kg child requiring 1800 mg amoxicillin daily:
Option 1: Augmentin ES-600 (Preferred)
- Dose: 6 mL (600 mg amoxicillin) BID
- Provides: Exactly 90 mg/kg/day as per FDA labeling 6
- Clavulanate: 42.9 mg per 5 mL (lower than standard formulations, reducing GI side effects)
Option 2: Standard Augmentin Suspension
- Augmentin 400 mg/5 mL suspension: 11.25 mL (900 mg) BID
- Provides: 90 mg/kg/day with higher clavulanate content (57 mg/5 mL)
Option 3: High-Dose Amoxicillin Alone
- If β-lactamase-producing organisms are not a concern, use amoxicillin 90 mg/kg/day without clavulanate 1
Duration of Therapy
Prescribe for 10 days 1. While shorter courses may be effective for mild disease, 10-day courses have the strongest evidence base, particularly for community-acquired pneumonia 1. The guidelines emphasize using the shortest effective duration to minimize resistance selection, but 10 days remains the standard-of-care benchmark.
Common Pitfalls to Avoid
- Do not substitute adult tablets for pediatric weight-based dosing in children <40 kg 5
- Do not interchange Augmentin formulations—ES-600 contains different clavulanate ratios than standard suspensions and cannot be substituted 6
- Do not underdose to avoid side effects—subtherapeutic dosing drives resistance and treatment failure 1
- Reassess at 48-72 hours—children on adequate therapy should show clinical improvement within this timeframe 1
Evidence Quality Note
The IDSA/PIDS guidelines (2011) represent strong, consensus-based recommendations from major infectious disease societies 1, 2. The FDA labeling for Augmentin ES-600 specifically addresses high-dose therapy in children and provides weight-based dosing tables 6. Research confirms that twice-daily amoxicillin/clavulanate achieves equivalent efficacy to three-times-daily dosing with better compliance 7.
Bottom line: Use Augmentin ES-600 at 6 mL BID or standard Augmentin suspension at appropriately calculated volumes to achieve 90 mg/kg/day. Adult tablets systematically underdose pediatric patients and should not be used in this weight range.